ConductScience.org, home

Paper17520680

Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease.

Jones RJ and 6 others. Int J Cancer, 2007. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Papers, record 17520680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17520680

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease.
PubMed
Journal
Int J Cancer
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.19
iCite
Revised in PubMed
2016-03-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones RJRichard J
2Seaman WTWilliam T
3Feng WHWen-Hei
4Barlow EElizabeth
5Dickerson SSarah
6Delecluse HJHenri-Jacque
7Kenney SCShannon C

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epstein-Barr Virus InfectionsMajor topic
Interleukin-6Major topic
Lymphoproliferative DisordersMajor topic
Tumor Virus InfectionsMajor topic
Animals
Cell Line, Tumor
DNA-Binding Proteins
Enzyme-Linked Immunosorbent Assay
Flow Cytometry
Humans
Immediate-Early Proteins
Immunoblotting
Interleukin-10
Mice
Mice, SCID
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Trans-Activators
Viral Matrix Proteins
Viral Proteins

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01-CA19014NCI NIH HHSUnited StatesP01CA019014PubMed and NIHNIH RePORTER
R01-CA66519NCI NIH HHSUnited StatesR01CA066519PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42113877Playing both sides - Epstein-Barr Virus accumulates select cellular transcripts to counter virus-mediated host shut-off in lytic cells.PLoS Pathog2026https://conductscience.org/library/papers/42113877PubMed
42023228The immunosuppressive tumor microenvironment in post-transplant lymphoproliferative disorder: pathogenesis and novel therapeutic frontiers.Front Immunol2026https://conductscience.org/library/papers/42023228PubMed
41835621EBV-dUTPase Modulates Host Immune Responses Potentially Altering the Tumor Microenvironment in EBV-associated Malignancies.Curr Res HIV AIDS2016https://conductscience.org/library/papers/41835621PubMed
41144108Multi-omics profiling uncovers paradoxical Epstein-Barr virus involvement in autoimmune liver disease pathogenesis.AMB Express2025https://conductscience.org/library/papers/41144108PubMed
36560713Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.Viruses2022https://conductscience.org/library/papers/36560713PubMed
36242711The lytic phase of Epstein-Barr virus plays an important role in tumorigenesis.Virus Genes2023https://conductscience.org/library/papers/36242711PubMed
36113467Epstein-Barr virus: Biology and clinical disease.Cell2022https://conductscience.org/library/papers/36113467PubMed
35485636EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non-endemic region.Cancer Sci2022https://conductscience.org/library/papers/35485636PubMed
34625709Calcium-dependent signalling in B-cell lymphomas.Oncogene2021https://conductscience.org/library/papers/34625709PubMed
34339458Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.PLoS Pathog2021https://conductscience.org/library/papers/34339458PubMed
34073189An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness.Viruses2021https://conductscience.org/library/papers/34073189PubMed
33675667Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation.Nucleic Acids Res2021https://conductscience.org/library/papers/33675667PubMed
33228078Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis.Microorganisms2020https://conductscience.org/library/papers/33228078PubMed
32847852Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.J Virol2020https://conductscience.org/library/papers/32847852PubMed
32517128Oncogenic Properties of the EBV ZEBRA Protein.Cancers (Basel)2020https://conductscience.org/library/papers/32517128PubMed
32059024B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.PLoS Pathog2020https://conductscience.org/library/papers/32059024PubMed
30871092Novel Therapeutics for Epstein⁻Barr Virus.Molecules2019https://conductscience.org/library/papers/30871092PubMed
30052684A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.PLoS Pathog2018https://conductscience.org/library/papers/30052684PubMed
29899236Antiviral Drugs for EBV.Cancers (Basel)2018https://conductscience.org/library/papers/29899236PubMed
29723986EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies.Cancers (Basel)2018https://conductscience.org/library/papers/29723986PubMed

See all 37 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17520680

GET https://conductscience.org/api/papers/v1/17520680/cited_by?page=2